Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Orvosi Hetilap|November 8, 2016
[Quo vadis hematology?]Zsolt Matula, Gyöngyi Kudlik, Veronika Urbán S, et al.
International Journal of Molecular Sciences|March 29, 2023
The Effect of Belantamab Mafodotin on Primary Myeloma-Stroma Co-Cultures: Asymmetrical Mitochondrial Transfer between Myeloma Cells and Autologous Bone Marrow Stromal CellsZsolt Matula, Ferenc Uher, István Vályi-Nagy, et al.
Orvosi Hetilap|November 10, 2015
[At the border of pluri- and multipotency: the neural crest stem cells]Gyöngyi Kudlik, Zsolt Matula, Tamás Kovács, et al.
Cancer Genetics|October 14, 2017
First cloned human immortalized adipose derived mesenchymal stem-cell line with chimeric SS18-SSX1 gene (SS-iASC)Dóra Mihály, Zsolt Matula, Yi-Che Changchien, et al.
Vaccines|April 23, 2022
Antibody and T Cell Responses against SARS-CoV-2 Elicited by the Third Dose of BBIBP-CorV (Sinopharm) and BNT162b2 (Pfizer-BioNTech) Vaccines Using a Homologous or Heterologous Booster Vaccination StrategyZsolt Matula, Márton Gönczi, Gabriella Bekő, et al.
Stem Cells and Development|August 8, 2014
ABCG2 is a selectable marker for enhanced multilineage differentiation potential in periodontal ligament stem cellsÁron Szepesi, Zsolt Matula, Anna Szigeti, et al.
Biochemical and Biophysical Research Communications|May 5, 2012
Combined introduction of Bmi-1 and hTERT immortalizes human adipose tissue-derived stromal cells with low risk of transformationPéter Tátrai, Áron Szepesi, Zsolt Matula, et al.
Cancers|July 24, 2021
Stromal Cells Serve Drug Resistance for Multiple Myeloma via Mitochondrial Transfer: A Study on Primary Myeloma and Stromal CellsZsolt Matula, Gábor Mikala, Szilvia Lukácsi, et al.
Geroscience|October 11, 2021
Comparison of antibody and T cell responses elicited by BBIBP-CorV (Sinopharm) and BNT162b2 (Pfizer-BioNTech) vaccines against SARS-CoV-2 in healthy adult humansIstván Vályi-Nagy, Zsolt Matula, Márton Gönczi, et al.
Frontiers in Immunology|October 25, 2024
High prevalence of long COVID in anti-TPO positive euthyroid individuals with strongly elevated SARS-CoV-2-specific T cell responses and moderately raised anti-spike IgG levels 23 months post-infectionZsolt Matula, Viktória Király, Gabriella Bekő, et al.
Pageof 3